We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Name | Symbol | Market | Type |
---|---|---|---|
Sanofi | NASDAQ:SNY | NASDAQ | Depository Receipt |
Price Change | % Change | Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
-0.84 | -1.68% | 49.19 | 49.18 | 49.21 | 49.28 | 48.27 | 49.04 | 2,302,538 | 16:37:02 |
PARIS, February 8, 2017 /PRNewswire/ --
Sanofi, a global and diversified healthcare leader, reports results for 2016. Olivier Brandicourt, Chief Executive Officer of Sanofi, comments on the results.
Watch video interview and read transcript:
https://www.eurobusinessmedia.com/video/sanofi-fy-2016-results/?utm_source=ceo-direct&utm_medium=wire
Topics covered in the interview include:
- Q4 highlights
- Diabetes
- R&D pipeline
- Dividend
- Outlook
About Sanofi
Sanofi, a global healthcare leader, discovers, develops and distributes therapeutic solutions focused on patients' needs. Sanofi is organized into five global business units: Diabetes and Cardiovascular, General Medicines and Emerging Markets, Sanofi Genzyme, Sanofi Pasteur and Merial. Sanofi is listed in Paris (EURONEXT: SAN) and in New York (NYSE: SNY).
SOURCE Sanofi
Copyright 2017 PR Newswire
1 Year Sanofi Chart |
1 Month Sanofi Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions